Sunshine Biopharma Inc. Investment Income, Interest
Sunshine Biopharma Inc. (SBFM) reported Investment Income, Interest of $2 for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-09.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2021-08-09
- Sunshine Biopharma Inc. investment income, interest for the quarter ending 2021-06-30 was $2.00.
- Sunshine Biopharma Inc. investment income, interest for the quarter ending 2020-06-30 was $0.00.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month |
|---|---|---|
| 2021-06-30 | $2.00 10-Q · filed 2021-08-09 | $2.00 10-Q · filed 2021-08-09 |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-09 | $0.00 10-Q · filed 2021-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |